Brexpiprazole in patients with schizophrenia: overview of short- and long-term phase 3 controlled studies

Abstract

Overall, the results indicate brexpiprazole, used either short-term or as part of a long-term maintenance treatment programme, is an efficacious therapy option in adults with schizophrenia and has a favourable safety/tolerability profile.